Consistent, high-volume, low-cost Colombian cannabis company selling into multiple global markets
A reputable Colombian medical cannabis enterprise, renowned for its consistent year-round production of quality cannabis at a significant scale, is actively seeking a strategic equity partner
Listing ID:
14944947750
Licence(s) Held:
CUMCS GACP & ICA BPA. The company is licensed to produce, extract and export cannabis from Colombia. Holds CUMCS GACP certification, supporting commercial contracts and an efficient, streamlined supply chain
Seeking USD $3 million strategic equity partner to fulfill $15m in signed contracts, capacity expansion, and advance toward EU-GMP certification in 2026
Listing Details:
With low-cost production and international exports, this Colombian cannabis company is seeking a $3M partner. Backed by $15M in contracts, it offers year-round premium strains and is targeting EU-GMP certification by 2026. Proven scalability and high-margin potential make this an attractive global opportunity.
Well-established and well-positioned Colombian medical cannabis company poised to become a leading and reliable global wholesale cannabis supplier with consistent supply year-round.
Export track record: >10 successful international shipments; one of a small number of Colombian licensees consistently exporting to regulated markets
Attractive high growth business model with recurrent & predictable revenues and high margin potential (60%+ EBITDA margin at scale)
Low-cost, high-margin model driven by Colombian production advantages between $0.10-$0.30 cost per gram vs. $0.80 – 1.50 per gram in EU / North America.
Proven scale with past rolling harvests of up to 1,000 kgs per month. Demonstrating ability to scale to meet market demand
$15M+ in multi-year, recurring revenue contracts secured across Australia, Germany, the UK, Italy, Malta and Poland
Company has 30 high quality, registered strains in their genetics library, all developed in Colombia, with one of Colombia’s leading genetics teams under the leadership of their Canadian cultivation and genetics experts
Company also has a number of unique strains that are testing at 24-27% THC in the pipeline and more underway. Adding to genetics library and fine tuning the production approach for maximum cannabinoid and terpene plant expression.
Highly experienced management team and leadership governance, with strong expertise in cultivation, pharma and distribution. Board includes former regional President of Philip Morris International and Director of Imperial Brands ($30bn market cap).
Consistent quality meeting EU Pharmacopeia and TG93 standards; recently achieved CUMCS-GACP certification
Upgraded infrastructure to meet EU-GACP standards and initiated EU-GMP roadmap for 2026 to enhance quality, streamline supply chains, and boost margins
One greenhouse currently operational, with a second set to launch in Q3 2025. The site has capacity for 8 more greenhouses, offering full monetization of licensed land and ~$1–$4M+ in annual revenue potential per greenhouse
14944947750
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
28790904174
Licensed 8,500 ft² Cannabis Cultivation & Nursery Facility on 23 Acres Near Montreal, QC for $1.7M OBO
Opportunity to acquire a fully built-out, cannabis cultivation buildings located 30 minutes east of Montreal, featuring two purpose-built cultivation and nursery buildings on 23 acres for 1.7M o.b.o
44498920359
Early-Stage UK Medical Cannabis Platform – Licensed Market Entry Opportunity
Unique opportunity to invest in a pre-operational UK medical cannabis platform being established through a structured regulatory and licensing pathway, led by an experienced sector operator and set to operate all steps from import to patient.
54492796721
Profitable German direct-to-patient medical cannabis platform for €1.95M OBO — €3M+ revenue, 25% profit contribution, fully operational asset package
Unique opportunity to acquire a fully operational, profitable e-health platform serving medical cannabis patients across Germany through an integrated online consultation, prescription, and pharmacy fulfilment model.